Although treatment with cystic fibrosis transmembrane conductance regulator modulator therapies has resulted in a significant reduction in the clinical and psychosocial burden of CF lung disease, a substantial residual burden still exists. Given the expected increases in life expectancy following the introduction of CFTR modulator therapies, this burden is likely to continue into old age.
Lung Sask in collaboration with RESPTREC® offers the Professional Education Portal as a method for respiratory educators and health care providers to enhance their professional learning with continuing education opportunities.
Over 6000+ more articles available in the Professional Education Portal.
Read articles and watch video presentations on the most recent research, position papers and guidelines. Track your CE time with the provided logbook.